News | September 28, 2006

Statement Issued in Support of FDA Acting Commissioner Confirmation Statement Issued in Support of FDA Acting Commissioner Co

The Consumer Healthcare Products Association issued the following statement in support of today’s U.S. Senate Committee on Health, Education, Labor and Pensions (Senate HELP Committee) confirmation of acting Commissioner of the U.S. Food and Drug Administration (FDA) Andrew von Eschenbach:

"CHPA commends Senate HELP Committee Chair Michael Enzi (R-Wyo.), Ranking Member Edward Kennedy (D-Mass.), and all of the distinguished members of the full committee for their progress in the confirmation of acting FDA Commissioner Andrew von Eschenbach to permanently head the agency. As one of the strongest regulatory agencies in the world, the United States Food and Drug Administration continues to play a critical and increasingly important role in protecting the health of all Americans. CHPA has long recognized and supported an FDA Commissioner with solid scientific and medical credentials to lead this vital agency and feels strongly that Dr. von Eschenbach’s professional background and commitment to improving public health will serve this important regulatory agency well. We are hopeful that the U.S. Senate will move swiftly on floor consideration of the FDA Commissioner."

Related Content

News | October 25, 2007
October 26, 2007 - 3M and Zargis Medical Corp., a spin-off from Siemens Corporate Research and a majority-owned subsi
News | September 28, 2006
HHS Secretary Mike Leavitt named Leslie Norwalk as acting administrator for the CMS effective Oct. 15.
News | September 28, 2006
The American Society for Therapeutic Radiology and Oncology (ASTRO) has promoted two long-term employees in a move to